rs121918592
This is a missense variant in the RYR1 gene.
Key Literature Trait Associations
Malignant Hyperthermia Susceptibility
RYR1 R614C is one of the most common malignant hyperthermia (MH) susceptibility mutations, affecting the ryanodine receptor 1 in skeletal muscle. Carriers experience potentially fatal hypermetabolic crisis — characterized by rapidly rising body temperature, muscle rigidity, and metabolic acidosis — when exposed to volatile anesthetics (sevoflurane, desflurane) or succinylcholine. Pre-surgical genetic screening can be lifesaving, as non-triggering anesthetics (such as propofol and opioids) must be used for MH-susceptible individuals.
▶ClinVar annotation
Malignant hyperthermia, susceptibility to, 1; not provided; RYR1-related disorder
View on ClinVar →▶Research that mentions this SNP (1)
▶Aktuelle Aspekte der Diagnostik der malignen HyperthermieCase reportN=1,456Rüffert H. et al.(2002)· Der Anaesthesist
This is a retrospective clinical and molecular genetic study of 1,456 patients with suspected malignant hyperthermia (MH) evaluated at the Leipzig MH Center from 1986-2001. The in vitro contracture test (IVCT) identified 376 MH-susceptible (MHS), 121 MH-equivocal (MHE), and 921 MH-negative (MHN) individuals. Molecular genetic screening of the RYR1 gene in 99 families identified mutations in 46 families (46.5%), including 18 different mutations, of which 4 (Arg401Cys, Ile2182Phe, Gly2375Ala, Ile2453Thr) were novel. The study demonstrates that RYR1 molecular testing complements IVCT for comprehensive MH diagnostics and can clarify unusual cases including de novo mutations and homozygous mutation carriers.
Gene information from NCBI Gene. Variant classifications from ClinVar.
Community Wiki
No community notes yet for this variant. Sign in to start one.
Comments
Sign in to join the discussion.
Loading comments…